116 Grants (Page 2 of 5)
2014
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS082284-02), $337,451USD, 08/15/2013 -- 05/31/2018
 
The Indiana Cutaneous Biological Research Training Program
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5T32AR062495-02), $138,483USD, 04/01/2013 -- 03/31/2018
 
Toward drug treatment of spinal muscular atrophy: Mechanism of action
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS087379-01A1), $260,650USD, 08/15/2014 -- 07/31/2016
2013
Functions of Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-10), $281,939USD, 04/08/2004 -- 01/31/2015
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS082284-01A1), $340,871USD, 08/15/2013 -- 05/31/2018
2012
Cooperative lead development program for treatment of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R01HD064850-03), $596,573USD, 09/07/2010 -- 05/31/2014
 
Functions of Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-09), $299,935USD, 04/08/2004 -- 01/31/2015
2011
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-19), $312,214USD, 09/24/1993 -- 05/31/2013
 
Cooperative lead development program for treatment of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R01HD064850-02), $640,547USD, 09/07/2010 -- 05/31/2013
 
Functions of Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-08), $282,715USD, 04/08/2004 -- 01/31/2015
 
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA119904-04), $315,474USD, 01/15/2008 -- 12/31/2012
2010
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA058376-18), $341,289USD, 09/24/1993 -- 05/31/2012
 
Cooperative lead development program for treatment of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 1R01HD064850-01), $710,591USD, 09/07/2010 -- 05/31/2013
 
Functions of Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA107394-07), $252,560USD, 04/08/2004 -- 01/31/2015
 
Functions of Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA107394-06A2), $77,568USD, 04/08/2004 -- 07/17/2010
 
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA119904-03), $339,782USD, 01/15/2008 -- 07/17/2010
 
Testing Compounds that Increase SMN levels for Efficacy in Mouse Models of SMA
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 7R21NS064349-02), $218,425USD, 08/01/2009 -- 07/31/2012
2009
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA058376-16S1), $9,510USD, 06/01/2009 -- 10/31/2009
 
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-16), $360,126USD, 09/24/1993 -- 05/31/2012
 
Optimization of drug-like compounds for treatment of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R21HD057402-02), $253,125USD, 02/01/2008 -- 07/31/2010
 
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA119904-02), $339,522USD, 01/15/2008 -- 12/31/2011
 
Testing Compounds that Increase SMN levels for Efficacy in Mouse Models of SMA
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS064349-01A1), $265,611USD, 08/01/2009 -- 07/17/2010
2008
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-15), $360,126USD, 09/24/1993 -- 05/31/2012
 
Functions of Human Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-05), $310,653USD, 04/08/2004 -- 02/28/2010
 
High Throughput Screen for SMA
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Mental Health (NIMH) (ID: 1R03MH084179-01), $25,000USD, 06/11/2008 -- 05/31/2009